Bright Minds Biosciences's market cap is currently ―. The company's EPS TTM is C$-1.771; its P/E ratio is -0.77; Bright Minds Biosciences is scheduled to report earnings on May 27, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Dec 22	Sep 22	Jun 22	Mar 22
Income Statement	-
Total Revenue	-	C$ 0.00	-	C$ 0.00	C$ 0.00
Gross Profit	-	-	-	-	-
EBIT	-	C$ -2.26M	-	C$ -2.66M	C$ -4.48M
EBITDA	-	C$ -2.24M	-	C$ -2.66M	C$ -4.48M
Net Income Common Stockholders	-	C$ -2.34M	-	C$ -2.66M	C$ -4.49M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	C$ 6.75M	C$ 11.21M	C$ 11.63M	C$ 8.64M	C$ 11.47M
Total Assets	C$ 6.88M	C$ 11.55M	C$ 12.09M	C$ 8.82M	C$ 11.76M
Total Debt	C$ 73.55K	C$ 124.48K	C$ 139.91K	C$ 0.00	C$ 0.00
Net Debt	C$ -6.67M	C$ -11.09M	C$ -11.49M	C$ -8.64M	C$ -11.47M
Total Liabilities	C$ 280.86K	C$ 582.66K	C$ 1.54M	C$ 385.32K	C$ 1.00M
Stockholders Equity	C$ 6.60M	C$ 10.97M	C$ -24.17M	C$ 8.43M	C$ 10.76M
Cash Flow	-
Free Cash Flow	-	C$ -2.66M	-	C$ -2.86M	C$ -3.65M
Operating Cash Flow	-	C$ -2.66M	-	C$ -2.86M	C$ -3.65M
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	C$ 2.25M	-	C$ 12.00K	C$ 1.68K

Currency in CAD

Bright Minds Biosciences Earnings and Revenue History

Income Statement >

Bright Minds Biosciences Debt to Assets

Balance Sheet >

Bright Minds Biosciences Cash Flow

Cash Flow >

Bright Minds Biosciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing